Cargando…
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Autor principal: | Jang, Gwang Cheon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702119/ https://www.ncbi.nlm.nih.gov/pubmed/31319648 http://dx.doi.org/10.3345/kjp.2019.00472 |
Ejemplares similares
-
Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014) -
Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital
por: Lee, Jung Eun, et al.
Publicado: (2020) -
Why should we continue to learn?
por: Golnik, Karl
Publicado: (2017) -
Oxcarbazepine-induced tardive dyskinesia: A rare adverse reaction
por: Hergüner, M. Özlem, et al.
Publicado: (2010) -
Critical incident reporting: Why should we bother?
por: Tewari, Anurag, et al.
Publicado: (2013)